Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies

Peter C. Austin · Pharmaceutical Statistics · 2010 · 3.9K citations · Full text

Public Health, Biostatistics, Causal Inference +12

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

Wayne A. Ray · American Journal of Epidemiology · 2003 · 1.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet · 2008 · 1.4K citations

Medicine, Immunology, Pharmacology +16

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Paul Emery, Edward Keystone, Hans‐Peter Tony et al. · Annals of the Rheumatic Diseases · 2008 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A combined comorbidity score predicted mortality in elderly patients better than existing scores

Joshua J. Gagne, Robert J. Glynn, Jerry Avorn et al. · Journal of Clinical Epidemiology · 2011 · 1K citations · Full text

Medicine, Geriatric Medicine, Geriatric Assessment +13